Search
Harvard Bioscience Inc
HBIOAdd to Watchlist
8.900USD
+0.100+1.14%
Close 10-30 16:00（ET）
40.49MMarket Cap
LossP/E TTM
Harvard Bioscience Inc (HBIO) Stock Price Target & Forecast
Analyst Rating
Based on 2 analysts giving stock ratings to Harvard Bioscience Inc in the past month.
Buy
0 Strong Buy
1 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
7.500USD-10.93%
HBIO Analyst Recommendation Trends
In the current month, HBIO has received 1 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. HBIO average Analyst price target in the last month is 7.500.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
HBIO Analyst Rating for Peer Comparison
Updated: Nov 1, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Intuitive Surgical Inc
ISRG
11
14
8
1
0
34
Boston Scientific Corp
BSX
7
14
11
1
0
33
Edwards Lifesciences Corp
EW
10
15
6
0
0
31
Thermo Fisher Scientific Inc
TMO
10
14
6
0
0
30
Veeva Systems Inc
VEEV
8
13
7
1
0
29
Danaher Corp
DHR
11
13
3
0
0
27
Agilent Technologies Inc
A
6
11
7
0
0
24
Waters Corp
WAT
8
10
6
0
0
24
GE Healthcare Technologies Inc
GEHC
6
10
7
0
0
23
Resmed Inc
RMD
3
8
10
1
1
23
Financial Forecasting
Based on analysts' estimates, HBIO EPS is projected to reach -0.170 in FY2026Q3, following reported EPS of -0.643 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
0.35
-0.62
-0.21
-0.17
0.23
Actual
-0.64
-0.77
-0.64
--
--
Surprise
-282.37%
-23.46%
-206.17%
--
--
FAQs
What is Harvard Bioscience Inc's expected revenue for the next quarter?
Harvard Bioscience Inc's expected revenue is 21.80M.
What is Harvard Bioscience Inc's price target?
Analysts forecast that Harvard Bioscience Inc's price target is USD 7.50, with the highest forecast at USD 7.50 and the lowest forecast at USD 7.50.
How have Harvard Bioscience IncHBIO's recent earnings per share performed?
The market expectation was USD -0.64, while Harvard Bioscience IncHBIO's earnings per share (EPS) for the previous quarter was USD -0.77. EPS for the next quarter is expected at USD -0.17.
What is the analyst rating for Harvard Bioscience Inc?
Based on the ratings of Harvard Bioscience Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.